-
Design, Implementation, Data Analysis on the Time-Motions Studies: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Bimekizumab’s Synergistic Economic Impact Across Four Indications in France
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of High-Energy High-Protein (HEHP) Oral Nutritional Support (ONS) for the Treatment of Disease-Related Malnutrition (DRM) in Cancer Patients in the French Community Setting
Sep 9, 2025, 16:22 PM -
Unmet Needs in Late-Line Metastatic Colorectal Cancer in Portugal: An Expert-Informed Epidemiological Forecast
Sep 9, 2025, 16:22 PM -
Evaluating the Digital Transformation in Healthcare: Adoption, Challenges, and Opportunities
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Costs Associated With Malignant Brain Tumors in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries
Sep 9, 2025, 16:22 PM -
Real-World Evidence of Atezolizumab in Unresectable Recurrent NSCLC: Insights From Japan's Next-Generation Medical Infrastructure Act
Sep 9, 2025, 16:22 PM -
Exploring Beyond the Gut: A Qualitative Study of Extraintestinal Symptoms in Ulcerative Colitis and Crohn's Disease
Sep 9, 2025, 16:22 PM -
Comparative Efficacy of Asciminib vs. Second-Generation TKIs in Newly Diagnosed PhCML Using Unanchored Matching-Adjusted Indirect Comparisons
Sep 9, 2025, 16:22 PM -
An Economic Evaluation of Risankizumab vs. Adalimumab in Moderate to Severe Plaque Psoriasis Adult Patients in Egypt
Sep 9, 2025, 16:22 PM -
An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Genetic Testing for Optimizing Warfarin Therapy in Mechanical Heart Valve Patients: Insights From Qatar
Sep 9, 2025, 16:22 PM -
Common Criticism of Patient-Reported Outcomes (PRO) in Health Technology Assessments (HTA) by the Institute for Quality and Efficiency in Healthcare (IQWiG) in Breast Cancer and Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
Standardizing Point-of-Care mRNA-Based Gene Therapy Production in Europe: A Cost and Capacity Analysis of the Nanospresso Platform
Sep 9, 2025, 16:22 PM -
Maximizing Profits Through Pricing: Opportunities in Portugal's Pharma Sector
Sep 9, 2025, 16:22 PM -
The Safety and Effectiveness of Drug-Induced Sleep Endoscopy in Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Addressing the Inherent Challenges of the French National Claims Database (SNDS) Through Algorithms to Identify Patients With Diffuse Large B-cell Lymphoma (DLBCL) and Their Chemotherapy Treatments
Sep 9, 2025, 16:22 PM -
Evaluating the Efficacy of Artificial Intelligence Models as Suitable Screening Tools in Systematic Reviews: The Example of Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure Treatment
Sep 9, 2025, 16:22 PM -
From GVD to HTA: Preparing for Success in the EU JCA Era With GenAI-Enhanced Efficiency
Sep 9, 2025, 16:22 PM
